Efficacy and safety of extended-release carbidopa–levodopa (IPX203) versus immediate-release carbidopa–levodopa for Parkinson's disease: A systematic review
Ahmed Attar, Hasen H Aljadani, Khalid F Barwais, Abdalmajed A Alqsair, Faisal A Alharbi, Harith M Alharith, Abdullah A Fallatah, Mumen H Halabi, Alqassem Y Hakami, Nirmeen Zagzoog · 2026
Read Efficacy and safety of extended-release carbidopa–levodopa (IPX203) versus immediate-release carbidopa–levodopa for Parkinson's disease: A systematic review by Ahmed Attar, Hasen H Aljadani, Khalid F Barwais, Abdalmajed A Alqsair, Faisal A Alharbi, Harith M Alharith, Abdullah A Fallatah, Mumen H Halabi, Alqassem Y Hakami, Nirmeen Zagzoog (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13539026.txt.
Description
Ahmed Attar and co-authors review trials of a long-acting Parkinson's drug against its standard short-acting form, in a systematic review from 2026. Both forms pair carbidopa with levodopa, the mainstay for Parkinson's symptoms. The standard pills wear off fast, which leaves patients stuck in off periods.
Three randomized trials with 560 patients met the review's bar. The long-acting form, IPX203, lengthened good on-time, when symptoms are controlled with little jerky movement. It also cut off-time and improved motor scores more than the standard form. Overall side effect rates were alike, though more patients on the new form had effects emerge or quit treatment. The authors read the trade as a net gain for advanced patients.
Catalog record
| CREATOR | Ahmed Attar, Hasen H Aljadani, Khalid F Barwais, Abdalmajed A Alqsair, Faisal A Alharbi, Harith M Alharith, Abdullah A Fallatah, Mumen H Halabi, Alqassem Y Hakami, Nirmeen Zagzoog |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |